Senores Pharma’s ₹582 crore IPO garnered an overwhelming response from investors, receiving 97.86 times bids worth ₹31,172 crore.

Senores Pharma’s ₹582 crore IPO garnered an overwhelming response from investors, receiving 97.86 times bids worth ₹31,172 ...

India’s domestic carriers flew 1.42 crore passengers in November, up 12% year-on-year compared with 1.27 crore passengers in the same month last year, according to data shared by aviation regulator ...

After the slowdown in Q2, high-frequency indicators suggest a revival fuelled by festival demand and easing inflation, ...

83% of the total number of claims registered in their books and repudiated about 11% of them ...

83% of the total number of claims registered in their books and repudiated about 11% of them ...

83% of the total number of claims registered in their books and repudiated about 11% of them ...

During 2023-24, insurers have settled about 83% of the total number of claims registered in their books and repudiated about 11% of them ...

The decision comes at a time when most homes are equipped with in-built Wi-Fi, posing a potential threat to telecom operators' recently gaining ARPUs.

At the time of reporting, Akums Drugs shares were trading 0.7% lower at ₹593.70, with a market cap of ₹9,344.5 crore.

At the time of reporting, Akums Drugs shares were trading 0.7% lower at ₹593.70, with a market cap of ₹9,344.5 crore.

At the time of reporting, Akums Drugs shares were trading 0.7% lower at ₹593.70, with a market cap of ₹9,344.5 crore.